CLINICAL TRIALS PROFILE FOR TROSPIUM CHLORIDE; XANOMELINE TARTRATE
✉ Email this page to a colleague
All Clinical Trials for TROSPIUM CHLORIDE; XANOMELINE TARTRATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02831231 ↗ | Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium | Completed | Karuna Pharmaceuticals | Phase 1 | 2016-09-07 | This study is intended to determine whether the addition of trospium chloride to xanomeline tartrate will ameliorate the peripheral cholinergic side effects that have been previously experienced with xanomeline tartrate when administered alone. |
NCT02831231 ↗ | Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium | Completed | Karuna Therapeutics | Phase 1 | 2016-09-07 | This study is intended to determine whether the addition of trospium chloride to xanomeline tartrate will ameliorate the peripheral cholinergic side effects that have been previously experienced with xanomeline tartrate when administered alone. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TROSPIUM CHLORIDE; XANOMELINE TARTRATE
Condition Name
Clinical Trial Locations for TROSPIUM CHLORIDE; XANOMELINE TARTRATE
Trials by Country
Clinical Trial Progress for TROSPIUM CHLORIDE; XANOMELINE TARTRATE
Clinical Trial Phase
Clinical Trial Sponsors for TROSPIUM CHLORIDE; XANOMELINE TARTRATE
Sponsor Name